Evidence map›Paper›PMID 9472645›Full record

ArticleBritish journal of cancer1998

Reduced expression of deleted colorectal carcinoma (DCC) protein in established colon cancers.

T Goi, A Yamaguchi, G Nakagawara, T Urano, H Shiku, K Furukawa

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Polysaccharide K suppresses angiogenesis in colon cancer cells.Experimental and therapeutic medicine · 2012
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

T GoiThe First Department of Surgery, Fukui Medical School, Japan.
A Yamaguchi
G Nakagawara
T Urano
H Shiku
K Furukawa
University of Fukui · JPNagoya University · JPBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Using a bacterial fusion protein, a deleted colorectal carcinoma (DCC)-specific monoclonal antibody (MAb) 127-22 was established. Although MAb 127-22 reacted with almost all normal tissues, it did not react or only weakly reacted with many cancer cell lines, including colonic cancer lines, in flow cytometry. In Western immunoblots, the MAb reacted with a single 190-kDa molecule in a myeloma line Ara-10 extract. This component was scarcely detected in colonic cancer cell lines. Immunoblots of samples from 25 pairs of colonic cancers and adjacent normal tissues and from five adenoma tissues revealed that all normal colonic and adenoma tissues significantly expressed the DCC protein, whereas colonic cancer tissues showed poor expression. These results indicate not only deletion of and lowered mRNA expression of the DCC gene, but also marked reduction of DCC protein occurred in colonic cancer tissues. In addition, colonic cancer patients with liver metastasis expressed significantly lower levels of DCC than those without, suggesting the prognostic value of DCC expression.

Indexed as

Tumor Suppressor ProteinsAnimalsAntibodies, MonoclonalBlotting, WesternCell Adhesion MoleculesColonic NeoplasmsDCC ReceptorHumansImmunohistochemistryLiver NeoplasmsMiceReceptors, Cell SurfaceRNA, MessengerAntibodies, MonoclonalCell Adhesion MoleculesDCC protein, humanDcc protein, mouseDCC ReceptorReceptors, Cell SurfaceRNA, MessengerTumor Suppressor Proteins

Identifiers

PMID9472645
PMCPMC2151282
OpenAlexW2086615932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.